Welcome to our dedicated page for Axon Enterprise SEC filings (Ticker: AXON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Axon Enterprise’s mission to build a connected public-safety operating system spans everything from TASER devices to cloud SaaS, and that breadth shows up in dense SEC documents. If you’ve ever tried to track how Software & Sensors subscription revenue moves against TASER hardware margins or wanted clarity on potential product-liability litigation, the 250-page annual report can feel overwhelming.
Stock Titan turns those pages into plain English. Our AI-powered summaries highlight what matters in every Axon annual report 10-K simplified, flagging segment revenue swings, deferred subscription backlog, and regulatory risk factors. Need the latest Axon quarterly earnings report 10-Q filing? We post it the moment it hits EDGAR and layer on instant earnings report filing analysis, so you see gross-margin trends before the call even starts. Real-time alerts surface Axon insider trading Form 4 transactions, letting you monitor executive stock transactions Form 4 without refreshing EDGAR. Material contract wins or product recalls appear in an Axon 8-K material events explained card, and the proxy statement executive compensation section is broken down so you can compare pay to performance.
Whether you’re screening for Axon Form 4 insider transactions real-time, trying to understand Axon SEC documents with AI, or simply searching for “Axon SEC filings explained simply,” this page keeps every filing type—10-K, 10-Q, 8-K, 4, S-8, 13G—in one place. You’ll find:
- AI-generated key takeaways and risk flags
- Downloadable original documents and redlined updates
- Searchable table to filter by filing type or date
Save hours and make decisions faster with complete, continuously updated coverage of Axon’s regulatory disclosures, all distilled into insights you can act on.
Axon Enterprise (AXON) Chief Revenue Officer reported equity transactions tied to performance-based restricted stock units under the 2024 eXponential Stock Plan. On 08/28/2025, 31,620 shares were acquired at $0 upon certification that the first and second tranches met performance conditions, bringing beneficial ownership to 50,318 shares.
On 10/31/2025, 5,850 shares were disposed of at $711.34 to settle taxes from the first tranche vesting, leaving 44,468 shares beneficially owned. The first tranche vested on 10/01/2025; the second tranche will vest on 04/01/2026, each subject to continued employment. Shares delivered for each tranche are subject to a minimum holding period until the earlier of 12/31/2030 or the date a subsequent tranche vests, excluding shares withheld or sold for taxes. The filing notes it was submitted late due to an administrative error.
Axon Enterprise, Inc. furnished an 8-K announcing it issued a shareholder letter with financial results for the quarter ended September 30, 2025. The letter is provided as Exhibit 99.1 and the Item 2.02 information is furnished, not filed, under the Exchange Act.
AXON director and CEO Patrick W. Smith reported open-market sales totaling 10,000 shares of common stock on
Axon Enterprise, Inc. reported a proposed sale under Rule 144 of 10,000 common shares by an insider through UBS Financial Services on
Brittany Bagley, COO & CFO of Axon Enterprise (AXON), reported sales and tax-withholdings of company common stock in late September 2025. Restricted stock units vested and 14,430 shares were withheld to cover taxes on September 26, 2025. Under a Rule 10b5-1 trading plan adopted June 16, 2025, Bagley sold additional shares on September 29, 2025, in multiple trades: 566, 1,025, 205, 300, 1,829 and 1,075 shares at weighted-average prices ranging from about $709.80 to $716.70, with the reported weighted prices shown per line. After these transactions the filing shows Bagley beneficially owning 93,592 shares.
AXON ENTERPRISE, INC. Form 144 notice: The filer reports a proposed sale of 5,000 shares of Common stock through Morgan Stanley Smith Barney LLC on 09/29/2025, with an aggregate market value reported at $3,544,200.00 and a stated number of outstanding shares of 78,504,440. The securities were acquired as Restricted Stock Units on 09/26/2025 from the issuer and payment/consideration is listed as N/A. The filing also discloses a prior sale by Brittany Bagley of 870 shares on 09/15/2025 for gross proceeds of $672,724.89. Broker address and signature/attestation language are included in the notice.
Jennifer H. Mak, Chief Accounting Officer of Axon Enterprise, Inc. (AXON), reported a sale of 77 shares of common stock on 09/15/2025. The sale was effected under a Rule 10b5-1 trading plan adopted March 14, 2025, and related to shares issued upon settlement of vested restricted stock units. The reported sale price was $760 per share. After the transaction, Ms. Mak beneficially owned 15,003 shares directly. The Form 4 was signed by an attorney-in-fact on her behalf.
Brittany Bagley, identified as AXON's COO & CFO, reported a sale of 870 shares of AXON common stock on 09/15/2025 at a price of $773.247 per share. After the transaction she beneficially owned 113,022 shares, held directly. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Jeri Williams, a director of Axon Enterprise, Inc. (AXON), reported a sale of company stock on 09/11/2025. The Form 4 shows she disposed of 100 shares of Common Stock in one or more trades at a weighted average price of $752.5434 per share, with execution prices ranging from $752.50 to $752.61. Following the reported transaction, the filing lists 1,416 shares beneficially owned by Ms. Williams in a direct ownership form. The filing was signed on her behalf by an attorney-in-fact, Isaiah Fields.
Form 144 filed for AXON ENTERPRISE, INC. The notice reports a proposed sale of 870 shares of common stock through Morgan Stanley Smith Barney LLC on 09/15/2025 on NASDAQ with an aggregate market value of $672,724.89. Total shares outstanding listed are 78,504,440. The 870 shares consist of 143 shares acquired on 06/26/2024 and 727 shares acquired on 08/13/2025, both from restricted stock vesting under a registered plan; payments are marked as Not Applicable. The filer states there have been no sales by the person in the past three months and includes the standard representation that no undisclosed material adverse information is known.
FAQ
What is the current stock price of Axon Enterprise (AXON)?
What is the market cap of Axon Enterprise (AXON)?
